These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28655945)

  • 1. A Case of Refractory Langerhans Cell Histiocytosis Complicated with Hemophagocytic Lymphohistiocytosis Rescued by Cord Blood Transplantation with Reduced-intensity Conditioning.
    Washio K; Muraoka M; Kanamitsu K; Oda M; Shimada A
    Acta Med Okayama; 2017 Jun; 71(3):249-254. PubMed ID: 28655945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic Lymphohistiocytosis in Langerhans Cell Histiocytosis: A Case Report and Review of the Literature.
    Hinson ARP; Patel N; Kaplan J
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):24-27. PubMed ID: 31725543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans cell histiocytosis complicated with hemophagocytic lymphohistiocytosis in a boy with a novel XIAP mutation: A case report.
    Guo X; Li Q; Gao J
    Medicine (Baltimore); 2018 Nov; 97(44):e13019. PubMed ID: 30383659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory Langerhans cell histiocytosis with pulmonary aspergillosis by reduced-intensity conditioning cord blood transplantation.
    Hatakeyama N; Hori T; Yamamoto M; Inazawa N; Hirako Y; Tsutsumi H; Suzuki N
    Pediatr Transplant; 2010 May; 14(3):E4-10. PubMed ID: 19175514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis.
    Cooper N; Rao K; Goulden N; Webb D; Amrolia P; Veys P
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S47-50. PubMed ID: 18978744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic Lymphohistiocytosis in Langerhans Cell Histiocytosis: A Case Series and Literature Review.
    Tang X; Guo X; Gao J; Sun JJ; Wan Z
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e20-e25. PubMed ID: 34133378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.
    Veys PA; Nanduri V; Baker KS; He W; Bandini G; Biondi A; Dalissier A; Davis JH; Eames GM; Egeler RM; Filipovich AH; Fischer A; Jürgens H; Krance R; Lanino E; Leung WH; Matthes S; Michel G; Orchard PJ; Pieczonka A; Ringdén O; Schlegel PG; Sirvent A; Vettenranta K; Eapen M
    Br J Haematol; 2015 Jun; 169(5):711-8. PubMed ID: 25817915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
    Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis arising in a child with Langerhans cell histiocytosis.
    Dokmanovic L; Krstovski N; Jankovic S; Janic D
    Turk J Pediatr; 2014; 56(4):452-7. PubMed ID: 25818970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
    Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA
    Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
    Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.
    Chellapandian D; Hines MR; Zhang R; Jeng M; van den Bos C; Santa-María López V; Lehmberg K; Sieni E; Wang Y; Nakano T; Williams JA; Fustino NJ; Astigarraga I; Dunkel IJ; Abla O; van Halteren AGS; Pei D; Cheng C; Weitzman S; Sung L; Nichols KE
    Cancer; 2019 Mar; 125(6):963-971. PubMed ID: 30521100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.
    Hege K; Quigg T; Delgado D
    Pediatr Blood Cancer; 2016 Feb; 63(2):361-3. PubMed ID: 26488531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis.
    Erker C; Harker-Murray P; Talano JA
    Pediatr Clin North Am; 2017 Feb; 64(1):91-109. PubMed ID: 27894453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
    Nishi M; Nishimura R; Suzuki N; Sawada A; Okamura T; Fujita N; Kanai R; Yano J; Adachi S; Yasumi T; Sato E; Yasutomo K; Ishii E; Ohga S
    Am J Hematol; 2012 Jun; 87(6):637-9. PubMed ID: 22488407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
    Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
    Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal histiocytoses.
    Isaacs H
    Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical parental hematopoietic stem cell transplantation in pediatric refractory Langerhans cell histiocytosis.
    Jun Y; Quan QM; Bin W; Hua ZG; Li Z; Rui Z; Guang JC; Hao MH; Long DY; Jing Y; Xuan Z
    Pediatr Transplant; 2014 Jun; 18(4):E124-9. PubMed ID: 24641492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.